Executive Director, Investor Relations and Corporate Communications Bothell, Was

Executive Director, Investor Relations and Corporate Communications

Bothell, Washington, United States

Company Overview

Immunome is a clinical‑stage targeted oncology company committed to developing first‑in‑class and best‑in‑class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting‑edge therapies, including antibody‑drug conjugate therapies. Our pipeline includes varegacestat, a late‑clinical stage GSI; IM‑1021, a clinical‑stage ROR1 ADC; and IM‑3050, a FAP‑targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early‑stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

The Executive Director, Investor Relations will serve as the primary point of contact for the investment community and play a critical role in shaping Immunome’s external communications strategy. Reporting to the Chief Financial Officer, this leader will be responsible for articulating the company’s strategy, progress, and value proposition to investors, analysts, and other key financial stakeholders. The role requires deep understanding of the biotechnology sector and the ability to translate complex scientific and clinical information into clear, compelling narratives that enhance Immunome’s visibility and credibility in the capital markets.

Responsibilities

Investor Relations

• Execute the investor relations program in partnership with the CEO and CFO, ensuring clear, consistent, and disciplined communication with the capital markets.
• Own day‑to‑day IR execution, including investor and analyst meeting coordination, targeting support, CRM management, feedback capture, and follow‑up.
• Draft all core IR materials, including investor presentations, fact sheets, FAQs, earnings scripts, Q&A documents, and conference talk tracks.
• Serve as the primary point of contact for sell‑side analysts on logistics and clarifications; proactively identify and correct misinterpretations.
• Coordinate investor conferences, non‑deal roadshows, and other capital markets engagements.
• Track, synthesize, and report investor sentiment and market feedback to senior management and the Board.

Corporate Communications

• Lead execution of the corporate communications function, drafting press releases, corporate updates, pipeline and clinical announcements, and reactive statements.
• Translate complex scientific, clinical, and regulatory information into clear, accurate, and investable external messaging.
• Partner closely with Legal and senior management to ensure Reg FD compliance, disclosure discipline, and appropriate risk framing.
• Manage PR and IR agencies, setting direction and maintaining a high bar for accuracy, clarity, and quality.
• Support media engagement and spokesperson preparation; manage inbound media inquiries as needed.
• Ensure consistency across all external‑facing materials and channels.

Cross‑functional Leadership

• Serve as the central point of coordination for external messaging across Finance, Clinical, Regulatory, Legal, and Business Development.
• Own the external communications calendar and disclosure cadence.
• Identify communication risks early and elevate judgment calls appropriately.
• Support special situations, including clinical data releases, financings, and issues

#J-18808-Ljbffr